Cell turnover of the gastric mucosa is reduced by clanobutin.
4-(4-chlor-N-(4-methoxyphenyl)-benzamido)-butanic acid (clanobutin) reduces gastric cell exfoliation at an oral dose of 1800 mg/day. A dose of 900 mg/day had no effect. It may thus exert its benefical effect on ulcer healing.